CA3064363C - Non-small cell lung cancer biomarkers and uses thereof - Google Patents

Non-small cell lung cancer biomarkers and uses thereof Download PDF

Info

Publication number
CA3064363C
CA3064363C CA3064363A CA3064363A CA3064363C CA 3064363 C CA3064363 C CA 3064363C CA 3064363 A CA3064363 A CA 3064363A CA 3064363 A CA3064363 A CA 3064363A CA 3064363 C CA3064363 C CA 3064363C
Authority
CA
Canada
Prior art keywords
biomarkers
biomarker
individual
nsclc
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3064363A
Other languages
English (en)
French (fr)
Other versions
CA3064363A1 (en
Inventor
Michael Riel-Mehan
Alex A. E. Stewart
Rachel M. Ostroff
Stephen Alaric Williams
Edward N. Brody
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Somalogic Operating Co Inc
Original Assignee
Somalogic Operating Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Operating Co Inc filed Critical Somalogic Operating Co Inc
Priority to CA3064363A priority Critical patent/CA3064363C/en
Publication of CA3064363A1 publication Critical patent/CA3064363A1/en
Application granted granted Critical
Publication of CA3064363C publication Critical patent/CA3064363C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G01N33/5752
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CA3064363A 2011-10-24 2011-10-24 Non-small cell lung cancer biomarkers and uses thereof Active CA3064363C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3064363A CA3064363C (en) 2011-10-24 2011-10-24 Non-small cell lung cancer biomarkers and uses thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2847188A CA2847188C (en) 2011-10-24 2011-10-24 Non-small cell lung cancer biomarkers and uses thereof
PCT/US2011/057499 WO2013062515A2 (en) 2011-10-24 2011-10-24 Lung cancer biomarkers and uses thereof
CA3064363A CA3064363C (en) 2011-10-24 2011-10-24 Non-small cell lung cancer biomarkers and uses thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2847188A Division CA2847188C (en) 2011-10-24 2011-10-24 Non-small cell lung cancer biomarkers and uses thereof

Publications (2)

Publication Number Publication Date
CA3064363A1 CA3064363A1 (en) 2013-05-02
CA3064363C true CA3064363C (en) 2022-05-17

Family

ID=48168748

Family Applications (3)

Application Number Title Priority Date Filing Date
CA3006793A Active CA3006793C (en) 2011-10-24 2011-10-24 Non-small cell lung cancer biomarkers and uses thereof
CA3064363A Active CA3064363C (en) 2011-10-24 2011-10-24 Non-small cell lung cancer biomarkers and uses thereof
CA2847188A Active CA2847188C (en) 2011-10-24 2011-10-24 Non-small cell lung cancer biomarkers and uses thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA3006793A Active CA3006793C (en) 2011-10-24 2011-10-24 Non-small cell lung cancer biomarkers and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2847188A Active CA2847188C (en) 2011-10-24 2011-10-24 Non-small cell lung cancer biomarkers and uses thereof

Country Status (15)

Country Link
EP (1) EP2771692B1 (enExample)
JP (1) JP5986638B2 (enExample)
KR (1) KR101921945B1 (enExample)
CN (2) CN103890586B (enExample)
AU (1) AU2011378427B8 (enExample)
BR (1) BR112014006432B8 (enExample)
CA (3) CA3006793C (enExample)
ES (1) ES2674318T3 (enExample)
IL (2) IL231426A (enExample)
IN (1) IN2014CN01787A (enExample)
MX (1) MX355416B (enExample)
NZ (1) NZ621733A (enExample)
SG (1) SG11201400375SA (enExample)
WO (1) WO2013062515A2 (enExample)
ZA (1) ZA201401476B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5905003B2 (ja) 2010-07-09 2016-04-20 ソマロジック・インコーポレーテッド 肺癌バイオマーカーとその使用
EP2994753B1 (en) * 2013-05-09 2018-03-07 The Procter and Gamble Company Method and system for assessing health condition
CN107075545A (zh) 2014-07-30 2017-08-18 哈佛学院院长及董事 探针文库构建
CN104263723B (zh) * 2014-09-15 2017-06-06 南京医科大学 一种与原发性肺癌辅助诊断相关的低频高外显性遗传标志物及其应用
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
KR102078310B1 (ko) * 2015-09-11 2020-02-19 주식회사 압타머사이언스 비소세포성 폐암 진단용 단백질 바이오마커 패널 및 이를 이용한 비소세포성 폐암 진단 방법
CN107849569B (zh) * 2015-11-05 2021-08-03 深圳华大生命科学研究院 肺腺癌生物标记物及其应用
US10731166B2 (en) * 2016-03-18 2020-08-04 Caris Science, Inc. Oligonucleotide probes and uses thereof
KR101853118B1 (ko) * 2016-09-02 2018-04-30 주식회사 바이오인프라생명과학 피험체의 폐암 진단을 위한 복합 바이오마커군, 이를 이용하는 폐암 진단용 키트, 복합 바이오마커군의 정보를 이용하는 방법 및 이를 수행하는 컴퓨팅 시스템
CN110140175A (zh) * 2016-11-08 2019-08-16 哈佛学院院长及董事 基质印迹和清除
WO2018158147A1 (en) * 2017-03-01 2018-09-07 Roche Diagnostics Gmbh Systems and methods for classifying a biological sample regarding the presence of an analyte
US11788123B2 (en) 2017-05-26 2023-10-17 President And Fellows Of Harvard College Systems and methods for high-throughput image-based screening
CN109116023B (zh) * 2018-06-14 2021-06-04 郑州大学第一附属医院 一种肺癌标志物抗-mmp12自身抗体及其应用
CN109470859A (zh) * 2018-11-04 2019-03-15 华东医院 一种外泌体蛋白作为鉴别肺结节良恶性标志物及其应用
EP3894583A4 (en) 2018-12-13 2022-11-09 President and Fellows of Harvard College AMPLIFICATION METHODS AND SYSTEMS FOR MERFISH AND OTHER APPLICATIONS
EP3671210A1 (en) * 2018-12-21 2020-06-24 Biosystems International KFT Lung cancer protein epitomic biomarkers
EP3924974A4 (en) * 2019-02-15 2022-11-16 Biodesix, Inc. PREDICTIVE TEST FOR THE IDENTIFICATION OF PATIENTS WITH EARLY STAGE NSCLC AND AT HIGH RISK OF RECIDENCE AFTER SURGICAL PROCEDURE
CN110473167B (zh) * 2019-07-09 2022-06-17 哈尔滨工程大学 一种基于深度学习的尿沉渣图像识别系统及方法
CN112892619B (zh) * 2019-12-04 2022-07-15 香港城市大学深圳研究院 弧形边缘截面的pdms母模、微流控阀和芯片及其制备
EP4241062A4 (en) * 2020-11-11 2024-01-17 George Mason Research Foundation, Inc. LASER ATTACHMENT MICRODISCISSION VISUALIZATION CHEMISTRY
KR102613772B1 (ko) * 2021-02-02 2023-12-14 제노마인(주) 폐암 혈액 바이오마커의 검출 방법 및 키트
WO2025144995A1 (en) * 2023-12-29 2025-07-03 Novelna Inc. Lung cancer detection proteins and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335170B1 (en) * 1999-02-22 2002-01-01 Torben F. Orntoft Gene expression in bladder tumors
US6596503B1 (en) * 2000-08-18 2003-07-22 East Carolina University Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
ATE483979T1 (de) * 2004-08-10 2010-10-15 Oncotherapy Science Inc Gen anln in verbindung mit nicht-kleinzelligem lungenkrebs und seine wechselwirkungen mit rhoa
JP2009502115A (ja) * 2005-07-27 2009-01-29 オンコセラピー・サイエンス株式会社 小細胞肺癌の診断方法
US20080305962A1 (en) 2005-07-29 2008-12-11 Ralph Markus Wirtz Methods and Kits for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapies
US8445198B2 (en) * 2005-12-01 2013-05-21 Medical Prognosis Institute Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
US8014957B2 (en) * 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
WO2008046911A2 (en) * 2006-10-20 2008-04-24 Exiqon A/S Novel human micrornas associated with cancer
GB0803192D0 (en) * 2008-02-22 2008-04-02 Mubio Products Bv SCLC biomarker panel
GB2478441B (en) * 2008-09-09 2013-03-27 Somalogic Inc Lung cancer biomarkers and uses thereof
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
CA3153682A1 (en) 2008-11-17 2010-05-20 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
US20110236903A1 (en) * 2008-12-04 2011-09-29 Mcclelland Michael Materials and methods for determining diagnosis and prognosis of prostate cancer
WO2011100472A1 (en) * 2010-02-10 2011-08-18 The Regents Of The University Of California Salivary transcriptomic and proteomic biomarkers for breast cancer detection
US9128101B2 (en) 2010-03-01 2015-09-08 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
BR112012025593A2 (pt) 2010-04-06 2019-06-25 Caris Life Sciences Luxembourg Holdings biomarcadores em circulação para doença

Also Published As

Publication number Publication date
IN2014CN01787A (enExample) 2015-05-29
WO2013062515A3 (en) 2014-04-17
JP5986638B2 (ja) 2016-09-06
AU2011378427A8 (en) 2015-08-27
CA2847188A1 (en) 2013-05-02
NZ621733A (en) 2015-05-29
BR112014006432B1 (pt) 2021-04-06
AU2011378427B2 (en) 2015-07-16
KR20140082840A (ko) 2014-07-02
AU2011378427A1 (en) 2013-05-16
CN106168624A (zh) 2016-11-30
EP2771692A2 (en) 2014-09-03
MX2014004860A (es) 2014-05-27
SG11201400375SA (en) 2014-04-28
CA3064363A1 (en) 2013-05-02
EP2771692B1 (en) 2018-04-18
AU2011378427B8 (en) 2015-08-27
BR112014006432A2 (pt) 2017-04-04
KR101921945B1 (ko) 2018-11-26
CA3006793A1 (en) 2013-05-02
CA2847188C (en) 2020-02-18
JP2015501154A (ja) 2015-01-15
ES2674318T3 (es) 2018-06-28
ZA201401476B (en) 2016-06-29
CN106168624B (zh) 2018-03-13
IL252163A0 (en) 2017-07-31
CN103890586B (zh) 2016-06-29
CN103890586A (zh) 2014-06-25
EP2771692A4 (en) 2015-08-26
MX355416B (es) 2018-04-18
IL231426A0 (en) 2014-04-30
BR112014006432B8 (pt) 2022-10-25
IL231426A (en) 2017-06-29
WO2013062515A2 (en) 2013-05-02
CA3006793C (en) 2020-02-18

Similar Documents

Publication Publication Date Title
CA3064363C (en) Non-small cell lung cancer biomarkers and uses thereof
US11041866B2 (en) Pancreatic cancer biomarkers and uses thereof
AU2015249113B2 (en) Lung cancer biomarkers and uses thereof
CA2809282C (en) Mesothelioma biomarkers and uses thereof
US20120101002A1 (en) Lung Cancer Biomarkers and Uses Thereof
US20120143805A1 (en) Cancer Biomarkers and Uses Thereof
WO2011031344A1 (en) Cancer biomarkers and uses thereof
WO2011043840A1 (en) Cancer biomarkers and uses thereof
US20120165217A1 (en) Cancer Biomarkers and Uses Thereof
WO2010042525A9 (en) Ovarian cancer biomarkers and uses thereof
US20220065872A1 (en) Lung Cancer Biomarkers and Uses Thereof
HK1196429B (en) Lung cancer biomarkers and uses thereof
HK1196429A (en) Lung cancer biomarkers and uses thereof
HK1153834B (en) Lung cancer biomarkers and uses thereof

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20191211